Description
sPLA2 Inhibitor is an orally active inhibitor of secreted phospholipases A2 IIA (sPLA2-IIA). It exhibits anti-inflammatory effects, and attenuates NF-κB signaling in lung cancer cells and protects against diet-induced metabolic syndrome in rats